Global Bovine Blood Plasma Derivatives 麻豆原创 will register a 4.3% CAGR in terms of revenue, the market size will reach USD 2.08 Billion by 2024, from USD 1.68 Billion in 2019.
Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.
Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market. Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world's three giants. In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%
North America plays an important role in global bovine blood plasma derivatives market, especially United States, which has great influence on the development of bovine blood plasma derivatives. In Europe market, Germany, UK, France and Italy are playing significant roles, especially Germany, which has absolute predominance in Europe market. The Asia-Pacific will take an increasing significant part in global bovine blood plasma derivatives market, due to the strong demand from China, India and Southeast Asian countries.
According to this study, over the next five years the Bovine Blood Plasma Derivatives market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 2080 million by 2024, from US$ 1680 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bovine Blood Plasma Derivatives business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Blood Plasma Derivatives market by product type, application, key manufacturers and key regions and countries.
This study considers the Bovine Blood Plasma Derivatives value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Scientific Research
Industrial Production
Feed
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Bovine Blood Plasma Derivatives consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Bovine Blood Plasma Derivatives market by identifying its various subsegments.
Focuses on the key global Bovine Blood Plasma Derivatives manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bovine Blood Plasma Derivatives with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Bovine Blood Plasma Derivatives submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.
Table of Contents
2019-2024 Global Bovine Blood Plasma Derivatives Consumption 麻豆原创 Report
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bovine Blood Plasma Derivatives Consumption 2014-2024
2.1.2 Bovine Blood Plasma Derivatives Consumption CAGR by Region
2.2 Bovine Blood Plasma Derivatives Segment by Type
2.2.1 Bovine Serum
2.2.2 FBS
2.2.3 Bovine Serum Albumin
2.2.4 Fibrinogen
2.2.5 Protein Ingredient
2.2.6 Other
2.3 Bovine Blood Plasma Derivatives Consumption by Type
2.3.1 Global Bovine Blood Plasma Derivatives Consumption 麻豆原创 Share by Type (2014-2019)
2.3.2 Global Bovine Blood Plasma Derivatives Revenue and 麻豆原创 Share by Type (2014-2019)
2.3.3 Global Bovine Blood Plasma Derivatives Sale Price by Type (2014-2019)
2.4 Bovine Blood Plasma Derivatives Segment by Application
2.4.1 Scientific Research
2.4.2 Industrial Production
2.4.3 Feed
2.4.4 Others
2.5 Bovine Blood Plasma Derivatives Consumption by Application
2.5.1 Global Bovine Blood Plasma Derivatives Consumption 麻豆原创 Share by Application (2014-2019)
2.5.2 Global Bovine Blood Plasma Derivatives Value and 麻豆原创 Share by Application (2014-2019)
2.5.3 Global Bovine Blood Plasma Derivatives Sale Price by Application (2014-2019)
3 Global Bovine Blood Plasma Derivatives by Players
3.1 Global Bovine Blood Plasma Derivatives Sales 麻豆原创 Share by Players
3.1.1 Global Bovine Blood Plasma Derivatives Sales by Players (2017-2019)
3.1.2 Global Bovine Blood Plasma Derivatives Sales 麻豆原创 Share by Players (2017-2019)
3.2 Global Bovine Blood Plasma Derivatives Revenue 麻豆原创 Share by Players
3.2.1 Global Bovine Blood Plasma Derivatives Revenue by Players (2017-2019)
3.2.2 Global Bovine Blood Plasma Derivatives Revenue 麻豆原创 Share by Players (2017-2019)
3.3 Global Bovine Blood Plasma Derivatives Sale Price by Players
3.4 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Bovine Blood Plasma Derivatives Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Bovine Blood Plasma Derivatives by Regions
4.1 Bovine Blood Plasma Derivatives by Regions
4.1.1 Global Bovine Blood Plasma Derivatives Consumption by Regions
4.1.2 Global Bovine Blood Plasma Derivatives Value by Regions
4.2 Americas Bovine Blood Plasma Derivatives Consumption Growth
4.3 APAC Bovine Blood Plasma Derivatives Consumption Growth
4.4 Europe Bovine Blood Plasma Derivatives Consumption Growth
4.5 Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth
5 Americas
5.1 Americas Bovine Blood Plasma Derivatives Consumption by Countries
5.1.1 Americas Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
5.1.2 Americas Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
5.2 Americas Bovine Blood Plasma Derivatives Consumption by Type
5.3 Americas Bovine Blood Plasma Derivatives Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Bovine Blood Plasma Derivatives Consumption by Countries
6.1.1 APAC Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
6.1.2 APAC Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
6.2 APAC Bovine Blood Plasma Derivatives Consumption by Type
6.3 APAC Bovine Blood Plasma Derivatives Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Bovine Blood Plasma Derivatives by Countries
7.1.1 Europe Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
7.1.2 Europe Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
7.2 Europe Bovine Blood Plasma Derivatives Consumption by Type
7.3 Europe Bovine Blood Plasma Derivatives Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Bovine Blood Plasma Derivatives by Countries
8.1.1 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
8.2 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Type
8.3 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends
10 麻豆原创ing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Bovine Blood Plasma Derivatives Distributors
10.3 Bovine Blood Plasma Derivatives Customer
11 Global Bovine Blood Plasma Derivatives 麻豆原创 Forecast
11.1 Global Bovine Blood Plasma Derivatives Consumption Forecast (2019-2024)
11.2 Global Bovine Blood Plasma Derivatives Forecast by Regions
11.2.1 Global Bovine Blood Plasma Derivatives Forecast by Regions (2019-2024)
11.2.2 Global Bovine Blood Plasma Derivatives Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States 麻豆原创 Forecast
11.3.2 Canada 麻豆原创 Forecast
11.3.3 Mexico 麻豆原创 Forecast
11.3.4 Brazil 麻豆原创 Forecast
11.4 APAC Forecast by Countries
11.4.1 China 麻豆原创 Forecast
11.4.2 Japan 麻豆原创 Forecast
11.4.3 Korea 麻豆原创 Forecast
11.4.4 Southeast Asia 麻豆原创 Forecast
11.4.5 India 麻豆原创 Forecast
11.4.6 Australia 麻豆原创 Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany 麻豆原创 Forecast
11.5.2 France 麻豆原创 Forecast
11.5.3 UK 麻豆原创 Forecast
11.5.4 Italy 麻豆原创 Forecast
11.5.5 Russia 麻豆原创 Forecast
11.5.6 Spain 麻豆原创 Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt 麻豆原创 Forecast
11.6.2 South Africa 麻豆原创 Forecast
11.6.3 Israel 麻豆原创 Forecast
11.6.4 Turkey 麻豆原创 Forecast
11.6.5 GCC Countries 麻豆原创 Forecast
11.7 Global Bovine Blood Plasma Derivatives Forecast by Type
11.8 Global Bovine Blood Plasma Derivatives Forecast by Application
12 Key Players Analysis
12.1 Thermo Fisher
12.1.1 Company Details
12.1.2 Bovine Blood Plasma Derivatives Product Offered
12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher News
12.2 GE Healthcare
12.2.1 Company Details
12.2.2 Bovine Blood Plasma Derivatives Product Offered
12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 GE Healthcare News
12.3 Merck (Sigma-Aldrich)
12.3.1 Company Details
12.3.2 Bovine Blood Plasma Derivatives Product Offered
12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Merck (Sigma-Aldrich) News
12.4 Moregate BioTech
12.4.1 Company Details
12.4.2 Bovine Blood Plasma Derivatives Product Offered
12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Moregate BioTech News
12.5 Gemini
12.5.1 Company Details
12.5.2 Bovine Blood Plasma Derivatives Product Offered
12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Gemini News
12.6 Atlanta Biologicals
12.6.1 Company Details
12.6.2 Bovine Blood Plasma Derivatives Product Offered
12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Atlanta Biologicals News
12.7 Tissue Culture Biologicals
12.7.1 Company Details
12.7.2 Bovine Blood Plasma Derivatives Product Offered
12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Tissue Culture Biologicals News
12.8 Bovogen
12.8.1 Company Details
12.8.2 Bovine Blood Plasma Derivatives Product Offered
12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Bovogen News
12.9 Biowest
12.9.1 Company Details
12.9.2 Bovine Blood Plasma Derivatives Product Offered
12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Biowest News
12.10 Internegocios
12.10.1 Company Details
12.10.2 Bovine Blood Plasma Derivatives Product Offered
12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Internegocios News
12.11 RMBIO
12.12 Biological Industries
12.13 VWR
12.14 Corning
12.15 Serana
12.16 Lanzhou Minhai
12.17 Zhejiang Tianhang Biotechnology
12.18 ExCell Bio
12.19 Jin Yuan Kang
12.20 American Protein Company
12.21 Sonac
13 Research Findings and Conclusion
听
听
*If Applicable.
